Navigation Links
Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
Date:5/14/2012

novel vaccine thermostabilization technology, ThermoVax™. We also continue to progress with development efforts of our oral BDP program for pediatric Crohn's disease and plan to initiate a Phase 2A clinical trial this year. We remain committed to enhancing our product development pipeline through internal efforts and external strategic alliances. We look forward to reporting on further progress this year regarding our Vaccine/BioDefense programs."

Soligenix's Recent Highlight:

On April 25, 2012, the Company announced further progress in the development of ThermoVax™.  Prior results had indicated that the Company's aluminum-adjuvanted ricin toxin vaccine, known as RiVax™, retained effectiveness and potency while stored at 40 degrees Celsius for one month combined with the ThermoVax™ technology. Confirmatory results have now extended these initial observations to more than three months when the vaccine is kept at 40 degrees Celsius. ThermoVax™ is able to produce stable and potent vaccine formulations by combining precise lyophilization technology with conventional aluminum adjuvants, secondary adjuvants (for rapid onset of immunity), and protein subunits.

About Soligenix, Inc.

Soligenix is a development stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid that has been initially developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of hematopoietic cell transplantation. Soligenix is also developing oral BDP for the prevention/treatment of other gastrointestinal disorders characterized by severe inflammation, including acute radiation enteritis
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
3. Soligenix Demonstrates Positive Proof of Concept with its Proprietary Vaccine Thermostabilization Technology
4. Soligenix Receives $574,000 in Non-Dilutive Financing from New Jerseys Technology Business Tax Certificate Transfer Program
5. Soligenix Initiates Next Generation Anthrax Vaccine Development Program Under Agreement With Harvard University
6. Soligenix Reports Third Quarter 2011 Financial Results
7. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
8. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
9. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
10. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
11. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 The preclinical contract research organization Absorption ... and safety testing of medical devices, announces that its Chief ... workshop " Drug Transporters in ADME: From the Bench to ... The title of Dr. Hidalgo,s talk is "Modern Tools for ... "Transporter Tools of the Future." The workshop, organized ...
(Date:4/20/2015)... Ingenuity Health, a leading provider of monitoring solutions to ... National Council of Behavioral Health annual conference in ... percent of the samples collected from patients with serious ... medication. ... Medication nonadherence can result ...
(Date:4/20/2015)... LINCOLNSHIRE, Ill. , April 20, 2015  U.S. pharmacy ... are expected to drift into the low double-digits by 2016, ... global talent, retirement and health solutions business of Aon ... plan design changes are projected to be 9.5 percent in ... 2016. Aon Hewitt predicts a similar rate of ...
Breaking Medicine Technology:Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... 26, 2011 Hamilton Company has been awarded a ... announced today. Hamilton Company, the Reno, NV-based global leader in ... investment in the manufacturing facility of its Swiss subsidiary Hamilton ... Named after Swiss national hero Wilhelm Tell, the Awards are ...
... 2011 Pinktimeline.com launched as a resource for the ... of First Response, and Zita West, fertility expert and midwife to ... for a baby. First Response has announced the launch of a ... trying for a baby, especially during the ,2-week wait., ...
Cached Medicine Technology:Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 2Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 3First Response Partners With Fertility Expert Zita West to Support Those Trying for a Baby 2
(Date:4/20/2015)... (PRWEB) April 20, 2015 Genuine fat loss ... diets and gym memberships in the past. But what failed ... results can be guaranteed by adhering to five simple ... diet. No matter how many hours one spends working at ... to lose weight., But a nutritional mean plan does not ...
(Date:4/20/2015)... Burlington, Vt. (PRWEB) April 20, 2015 ... environmental networks, is excited to announce that Kate Williams, the ... CEO, effective May 1, 2015. , Williams has been part ... nearly decade-long tenure as Executive Director of the Northern Forest ... Williams has dedicated her career to the stewardship of and ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Today ... Cancer-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian ... The Dream Team will focus on “DNA Repair ... that have identified DNA repair as a common ... the prevention and early detection of ovarian cancer ...
(Date:4/20/2015)... April 20, 2015 Grateful Dead ... united as one until 1995. The group was more than ... reggae, rock, bluegrass, folk, space rock, country, and other genres ... the ultimate jam band. The group was inducted into the ... total has sold more than 35 million records worldwide. ...
(Date:4/20/2015)... April 20, 2015 Northern Westchester ... & Medicaid Services introduced their new 5-star “Patient Experience” ... Assessment of Healthcare Providers and Systems) survey of hospital ... about their experiences during a recent hospital stay. ... 1, 2013 through June 30, 2014 can be reviewed ...
Breaking Medicine News(10 mins):Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3
... A study led by researchers in the Department of Neurosciences ... shows unexpected and extensive natural recovery after spinal cord injury ... the advance online edition of Nature Neuroscience , may ... patients with spinal cord injuries. While regeneration after ...
... the past three decades in at least one metropolitan ... the habit, according to research presented at the American ... a population-based, serial cross-sectional study of trends in cardiovascular ... each of its six surveys. Examining the smoking ...
... Diego - A brain scan with functional MRI (fMRI) is ... respond to "talk therapy," and so may not need to ... Their study, being presented at the annual meeting of ... and adolescents, ages 8 to16, who show fear when looking ...
... Americans require dialysis to treat kidney disease; of that ... caused by cardiovascular disease. Dialysis patients are at ... unclear why these deaths occur because little research has ... disease in this high-risk population. Northwestern ...
... SUNDAY, Nov. 14 (HealthDay News) -- New research suggests that ... black patients, even though it appears to double the risk ... findings, given that prior research has revealed that blacks are ... to experience a stroke, compared with white patients. Blacks also ...
... 14 (HealthDay News) -- In the months following the death of ... face a higher risk of heart attack or sudden cardiac death ... risk tends to dissipate within six months, the study authors said. ... directed toward the deceased person, the health and welfare of bereaved ...
Cached Medicine News:Health News:Research uncovers extensive natural recovery after spinal cord injury 2Health News:Smoking among some adults dropped dramatically in past three decades 2Health News:Smoking among some adults dropped dramatically in past three decades 3Health News:Smoking among some adults dropped dramatically in past three decades 4Health News:Smoking among some adults dropped dramatically in past three decades 5Health News:Smoking among some adults dropped dramatically in past three decades 6Health News:GUMC: fMRI predicts outcome to talk therapy in children with an anxiety disorder 2Health News:Patients receiving dialysis are at a heightened risk for sudden cardiac death 2Health News:Patients receiving dialysis are at a heightened risk for sudden cardiac death 3Health News:Vitamin D Shortage Not Tied to Stroke Deaths in Blacks: Study 2Health News:Death of Loved One May Trigger Elevated Heart Rate 2
Steerable catheter that is ideal for mapping unusual anatomy...
... The LASSO Circular Mapping Catheter from Biosense ... of circumferentially mapping the myocardial sleeves around ... allows the sequential assessment of PV potentials ... isolation. The circular LASSO curve with ...
Standard Deflectable Catheters...
... The reliable, easy-to-steer Bart EPXT ... shaft stability and curve control for ... point-of-tip actuation control supplies exceptional levels ... extraordinary family of small, medium and ...
Medicine Products: